Possessing identified the palmitoylation motif of APLNR, we designed a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the event of NCP, such as pain incidence, microglial activation, and inflammatory component release https://charlesm725olj9.blogtov.com/profile